Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline 5% versus mannitol 20% for cerebral edema in stroke patients
IRCT20120215009014N480Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in ischemic stroke and brain hemorrhage (ICH) comparing Mannitol 20% with Hypertonic saline 5% (2 arms). Primary endpoint: Cerebral edema. Started Sep 2023; status: completed.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
ischemic strokebrain hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20120215009014N480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N480.